Results 141 to 150 of about 9,953 (212)

Characterization of quinoxaline derivatives for protection against iatrogenically induced hearing loss. [PDF]

JCI Insight, 2021
Zallocchi M, Hati S, Xu Z, Hausman W, Liu H, He DZ, Zuo J.   +6 more
europepmc   +1 more source

Novel quinoxaline derivatives as dual EGFR and COX-2 inhibitors: synthesis, molecular docking and biological evaluation as potential anticancer and anti-inflammatory agents. [PDF]

RSC Adv, 2022
Ahmed EA, Mohamed MFA, Omran OA.
europepmc   +1 more source

Design and Synthesis of New Quinoxaline Derivatives as Potential Histone Deacetylase Inhibitors Targeting Hepatocellular Carcinoma: In Silico, In Vitro, and SAR Studies. [PDF]

Front Chem, 2021
Ma C, Taghour MS, Belal A, Mehany ABM, Mostafa N, Nabeeh A, Eissa IH, Al-Karmalawy AA.   +7 more
europepmc   +1 more source

Antimicrobial Activity of Quinoxaline Derivatives [PDF]

Chemical Science Transactions, 2014
openaire   +1 more source

New Quinoxaline Derivatives as Dual Pim-1/2 Kinase Inhibitors: Design, Synthesis and Biological Evaluation. [PDF]

Molecules, 2021
Oyallon B, Brachet-Botineau M, Logé C, Robert T, Bach S, Ibrahim S, Raoul W, Croix C, Berthelot P, Guillon J, Pinaud N, Gouilleux F, Viaud-Massuard MC, Denevault-Sabourin C.   +13 more
europepmc   +1 more source

Quinoxaline Derivatives in Cancer Therapy: Insights into Mechanisms of Action and Therapeutic Applications. [PDF]

Biomol Ther (Seoul)
Alhuwayshil J, Alnajim N, Dulaym SB, Alamre J, Alsubait A, Mohammed AE, Alghamdi SS.   +6 more
europepmc   +1 more source

EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF); Scientific Opinion on Flavouring Group Evaluation 17, Revision 2 (FEG.17Rev2): Pyrazine derivatives from chemical group 24 [PDF]

, 2011
Aeschbacher, Ajimu, Ajimu, Anderson, Babish, Babish, Beedham, Beedham, Beedham, Beutin, Burdock, Béraud, Cashman, Cashman, Cashman, Cashman, CoE, Cramer, D'Souza, Damani, Damani, Damani, Dutton, EC, EC, EC, EC, EC, EFFA, EFFA, Elfarra, Epler, Fung, Galloway, Hashimoto, Hawksworth, Hogben, Hoodi, IOFI, JECFA, JECFA, Knize, Koyama, Lee, Liang, Maiorino, McBain, McMahon, Moran, Nickson, Nickson, Nnane, Novotny, Ogura, Osborne, Oser, Oser, Oser, Oser, Oser, Oser, Parkinson, Posternak, Posternak, Rettie, Richardson, Rosenkranz, Sadeque, Sadeque, San RHC, SCF, SCF, Schranker, Sjödin, Stich, Stubley, Stubley, Sullivan, TNO, TNO, Topham, Tsai, Turesky, Vollmuth, Wallin, Wheldon, Whitehouse, Wild, Williams, Yamada, Yamada, Yamada, Yamamoto, Yamamoto, Yoshihara, Zeiger, Ziegler   +96 more
core   +1 more source

Assessment of antimicrobial activity of [1,2,4]triazolo[4, 3-a]quinoxaline derivatives individually and in combination with levofloxacin. [PDF]

Sci Rep
Harooni NS, Naimi-Jamal MR, Dekamin MG, Tahghighi A.   +3 more
europepmc   +1 more source

Discovery of new VEGFR-2 inhibitors based on bis([1, 2, 4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as anticancer agents and apoptosis inducers. [PDF]

J Enzyme Inhib Med Chem, 2021
Alsaif NA, Taghour MS, Alanazi MM, Obaidullah AJ, Al-Mehizia AA, Alanazi MM, Aldawas S, Elwan A, Elkady H.   +8 more
europepmc   +1 more source

EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF); Scientific Opinion on Flavouring Group Evaluation 17, Revision 3 (FGE.17Rev3): Pyrazine derivatives from chemical group 24 [PDF]

, 2011
Aeschbacher, Ajimu, Ajimu, Anderson, Babish, Beedham, Beedham, Beedham, Beutin, Burdock, Béraud, Cashman, Cashman, Cashman, Cashman, Cramer, D'Souza, Damani, Damani, Damani, Dutton, EC, EC, EC, EC, EC, EFFA, EFFA, Elfarra, Epler, Fung, Galloway, Hashimoto, Hawksworth, Hogben, Hoodi, IOFI, JECFA, JECFA, Knize, Koyama, Lee, Liang, Maiorino, McBain, McMahon, Moran, Nickson, Nickson, Nnane, Novotny, Oser, Oser, Oser, Oser, Oser, Parkinson, Posternak, Posternak, Rettie, Richardson, Rosenkranz, Roure Inc., Sadeque, Sadeque, SCF, Schranker, Sjödin, Stich, Stubley, Stubley, Sullivan, TNO, TNO, TNO, Topham, Tsai, Turesky, Vollmuth, Wallin, Whitehouse, Wild, Williams, Yamada, Yamada, Yamada, Yamamoto, Yamamoto, Yoshihara, Zeiger, Ziegler   +90 more
core   +1 more source